Review



ucb  (Pierre Fabre Group)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Pierre Fabre Group ucb
    Ucb, supplied by Pierre Fabre Group, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb/product/Pierre Fabre Group
    Average 86 stars, based on 1 article reviews
    ucb - by Bioz Stars, 2026-05
    86/100 stars

    Images



    Similar Products

    ucb et ultragenyx pharmaceuticals  (Johnson & Johnson)
    86
    Johnson & Johnson ucb et ultragenyx pharmaceuticals
    Ucb Et Ultragenyx Pharmaceuticals, supplied by Johnson & Johnson, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb et ultragenyx pharmaceuticals/product/Johnson & Johnson
    Average 86 stars, based on 1 article reviews
    ucb et ultragenyx pharmaceuticals - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ucb  (Novartis)
    86
    Novartis ucb
    Ucb, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb/product/Novartis
    Average 86 stars, based on 1 article reviews
    ucb - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ucb  (Amgen)
    86
    Amgen ucb
    Ucb, supplied by Amgen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb/product/Amgen
    Average 86 stars, based on 1 article reviews
    ucb - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ucb  (Pierre Fabre Group)
    86
    Pierre Fabre Group ucb
    Ucb, supplied by Pierre Fabre Group, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb/product/Pierre Fabre Group
    Average 86 stars, based on 1 article reviews
    ucb - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ucb zilocuplan  (Alexion Phrama)
    86
    Alexion Phrama ucb zilocuplan
    Disease course of following myasthenic exacerbation (ME) Time is shown in months; “0” indicates onset of ME. Age and gender of the patient are indicated in the upper left corner of the respective graph. The first five patients received standard-of-care treatment whereas the other seven patients underwent endplate protecting treatment. Abbreviations: SoC: standard-of-care; EPT: endplate protecting treatment; IVIG: intravenous immunoglobulins; PLEX: plasma exchange; QMG: quantitative myasthenia gravis score; MG-ADL: myasthenia gravis activities of daily living questionnaire; AZA: azathioprine, MMF: mycophenolate; MTX: methotrexate; CYC: cyclophosphamide; PYR: pyridostigmin; PRD: prednisolone; RAVU: ravulizumab; ZILO: <t>zilocuplan;</t> VYV: efgartigimod alfa
    Ucb Zilocuplan, supplied by Alexion Phrama, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb zilocuplan/product/Alexion Phrama
    Average 86 stars, based on 1 article reviews
    ucb zilocuplan - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ucb  (Daiichi Sankyo)
    86
    Daiichi Sankyo ucb
    Disease course of following myasthenic exacerbation (ME) Time is shown in months; “0” indicates onset of ME. Age and gender of the patient are indicated in the upper left corner of the respective graph. The first five patients received standard-of-care treatment whereas the other seven patients underwent endplate protecting treatment. Abbreviations: SoC: standard-of-care; EPT: endplate protecting treatment; IVIG: intravenous immunoglobulins; PLEX: plasma exchange; QMG: quantitative myasthenia gravis score; MG-ADL: myasthenia gravis activities of daily living questionnaire; AZA: azathioprine, MMF: mycophenolate; MTX: methotrexate; CYC: cyclophosphamide; PYR: pyridostigmin; PRD: prednisolone; RAVU: ravulizumab; ZILO: <t>zilocuplan;</t> VYV: efgartigimod alfa
    Ucb, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb/product/Daiichi Sankyo
    Average 86 stars, based on 1 article reviews
    ucb - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ucb  (Eli Lilly)
    86
    Eli Lilly ucb
    Disease course of following myasthenic exacerbation (ME) Time is shown in months; “0” indicates onset of ME. Age and gender of the patient are indicated in the upper left corner of the respective graph. The first five patients received standard-of-care treatment whereas the other seven patients underwent endplate protecting treatment. Abbreviations: SoC: standard-of-care; EPT: endplate protecting treatment; IVIG: intravenous immunoglobulins; PLEX: plasma exchange; QMG: quantitative myasthenia gravis score; MG-ADL: myasthenia gravis activities of daily living questionnaire; AZA: azathioprine, MMF: mycophenolate; MTX: methotrexate; CYC: cyclophosphamide; PYR: pyridostigmin; PRD: prednisolone; RAVU: ravulizumab; ZILO: <t>zilocuplan;</t> VYV: efgartigimod alfa
    Ucb, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb/product/Eli Lilly
    Average 86 stars, based on 1 article reviews
    ucb - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ucb  (Boehringer Ingelheim)
    86
    Boehringer Ingelheim ucb
    Disease course of following myasthenic exacerbation (ME) Time is shown in months; “0” indicates onset of ME. Age and gender of the patient are indicated in the upper left corner of the respective graph. The first five patients received standard-of-care treatment whereas the other seven patients underwent endplate protecting treatment. Abbreviations: SoC: standard-of-care; EPT: endplate protecting treatment; IVIG: intravenous immunoglobulins; PLEX: plasma exchange; QMG: quantitative myasthenia gravis score; MG-ADL: myasthenia gravis activities of daily living questionnaire; AZA: azathioprine, MMF: mycophenolate; MTX: methotrexate; CYC: cyclophosphamide; PYR: pyridostigmin; PRD: prednisolone; RAVU: ravulizumab; ZILO: <t>zilocuplan;</t> VYV: efgartigimod alfa
    Ucb, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ucb/product/Boehringer Ingelheim
    Average 86 stars, based on 1 article reviews
    ucb - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Disease course of following myasthenic exacerbation (ME) Time is shown in months; “0” indicates onset of ME. Age and gender of the patient are indicated in the upper left corner of the respective graph. The first five patients received standard-of-care treatment whereas the other seven patients underwent endplate protecting treatment. Abbreviations: SoC: standard-of-care; EPT: endplate protecting treatment; IVIG: intravenous immunoglobulins; PLEX: plasma exchange; QMG: quantitative myasthenia gravis score; MG-ADL: myasthenia gravis activities of daily living questionnaire; AZA: azathioprine, MMF: mycophenolate; MTX: methotrexate; CYC: cyclophosphamide; PYR: pyridostigmin; PRD: prednisolone; RAVU: ravulizumab; ZILO: zilocuplan; VYV: efgartigimod alfa

    Journal: Neurological Sciences

    Article Title: Delayed recovery following myasthenic exacerbation and subsequent endplate-protecting treatment

    doi: 10.1007/s10072-025-08617-6

    Figure Lengend Snippet: Disease course of following myasthenic exacerbation (ME) Time is shown in months; “0” indicates onset of ME. Age and gender of the patient are indicated in the upper left corner of the respective graph. The first five patients received standard-of-care treatment whereas the other seven patients underwent endplate protecting treatment. Abbreviations: SoC: standard-of-care; EPT: endplate protecting treatment; IVIG: intravenous immunoglobulins; PLEX: plasma exchange; QMG: quantitative myasthenia gravis score; MG-ADL: myasthenia gravis activities of daily living questionnaire; AZA: azathioprine, MMF: mycophenolate; MTX: methotrexate; CYC: cyclophosphamide; PYR: pyridostigmin; PRD: prednisolone; RAVU: ravulizumab; ZILO: zilocuplan; VYV: efgartigimod alfa

    Article Snippet: Potential conflicts of interest are related to the manufacturers of the endplate-protecting treatments discussed here: UCB (zilocuplan), Argenx (efgartigimod alfa), Alexion (ravulizumab).

    Techniques: Clinical Proteomics